Simultaneous cardio-cerebral infarction: a meta-analysis
T P Ng1, C Wong2, E L E Leong3
1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block Level 10, 119228, Singapore.
Insights
Cardio-cerebral infarction (CCI) is a rare condition with high mortality. This meta-analysis summarizes 44 cases, highlighting varied treatments like PCI and thrombectomy, and emphasizes the need for optimal strategies.
Area of Science:
- Cardiology
- Neurology
- Critical Care Medicine
Background:
- Cardio-cerebral infarction (CCI) involves simultaneous acute ischemic stroke and myocardial infarction.
- CCI has a low reported incidence (0.0009%) but presents significant treatment challenges due to the time-critical nature of both conditions.
- Published data on standardized treatment protocols for CCI are limited.
Purpose of the Study:
- To systematically review and summarize reported cases of cardio-cerebral infarction (CCI) in the medical literature.
- To identify and analyze the diagnostic and treatment modalities employed in CCI cases.
- To provide insights into the outcomes and mortality associated with CCI.
Main Methods:
- A meta-analysis was conducted.
- Literature search of four databases (PubMed, Embase, Scopus, Google Scholar) up to August 25, 2020.
- Independent review and data extraction by three authors from case reports and series.
Main Results:
- 44 CCI cases were identified from 37 publications.
- Treatments included percutaneous coronary intervention (PCI) with/without stent (52.3%), cerebral thrombectomy (22.7%), and coronary thrombectomy (18.2%).
- Medications comprised thrombolytics (45.5%), anticoagulants (22.7%), antiplatelets (18.2%), and combined anticoagulants/antiplatelets (25.0%). Mortality was 22.7%, with most deaths cardiac-related. Median days to death was 2.0, and median modified Rankin Score was 2.0.
Conclusions:
- Cardio-cerebral infarction (CCI) is associated with significant morbidity and mortality.
- Current treatment strategies for CCI are diverse, reflecting the complexity of managing simultaneous cardiac and neurological emergencies.
- Further research is essential to establish optimal diagnostic and therapeutic protocols for CCI patients.
Background/Introduction:
Cardio-cerebral infarction (CCI), which involves the simultaneous occurrence of acute ischaemic stroke and acute myocardial infarction, has a reported incidence of 0.0009%. Treatment of CCI presents a dilemma to physicians as both conditions are time critical. Despite the need for standardized treatment protocols, published data are sparse.
Aim:
We aimed to summarize the reported cardio-cerebral infarction cases in the literature.
Design:
Meta-analysis.
Methods:
Four databases, Pubmed, Embase, Scopus and Google Scholar were searched until 25 August 2020. A title and abstract sieve, full-text review and extraction of data were conducted independently by three authors.
Results:
A total of 44 cases of CCI were identified from 37 case reports and series; 15 patients (34.1%) were treated using percutaneous coronary intervention (PCI) with stent, 8 patients (18.2%) were treated with a PCI without stent, 10 patients (22.7%) were treated via a cerebral vessel thrombectomy and 8 patients (18.2%) were treated via a thrombectomy of a coronary vessel. For medications, 20 patients (45.5%) were treated with thrombolytics, 10 patients (22.7%) were treated with anticoagulants, 8 patients (18.2%) were treated with antiplatelets and 11 patients (25.0%) were treated with anticoagulants and antiplatelets. Of 44 patients, 10 patients died, and 9 of those were due to cardiac causes. Among the 44 patients, days to death was observed to be a median of 2.0 days (interquartile range (IQR): 1.5, 4.0). The modified Rankin Score was measured in nine patients, with a median score of 2.0 (IQR: 1.0, 2.5) being reported.
Discussion/Conclusion:
The condition of CCI has substantial morbidity and mortality, and further studies are needed to examine the optimal diagnostic and treatment strategies of these patients.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome III: Diagnostic Studies


